Skip to main content

Table 1 Summary of Outcome Measures

From: The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial

Measure

Direction of Score

# of Items

Timepoints Administered

Minimum Clinically Important Difference

Possible Range

Primary Outcome Measure

  EQ-5D-5L Index

↑ = better

5

T1, T2, T4, T5

+ 0.08 [23]

0–1

  EQ-FD-5 L VAS

↑ = better

5

T1, T2, T4, T5

+ 7 [23]

0–100

Secondary Questionnaires

  FACIT Fatigue

↑ = worse

13

T1, T2, T3, T4, T5, T6

−4 points [24]

0–52

  BPI

↑ = worse

11

T1, T2, T3, T4, T5, T6

Cohen’s d = 0.50 [25]

0–110

  DASS-21 Total

↑ = worse

21

T1, T2, T3, T4, T5, T6

 

0–63

  DASS Depression

↑ = worse

7

T1, T2, T3, T4, T5, T6

−5.01 points [26]

0–21

  DASS Anxiety

↑ = worse

7

T1, T2, T3, T4, T5, T6

−5.38 points [26]

0–21

  DASS Stress

↑ = worse

7

T1, T2, T3, T4, T5, T6

−4.90 points [26]

0–21